LifeMD (LFMD)
(Delayed Data from NSDQ)
$5.16 USD
-0.52 (-9.15%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $5.16 0.00 (0.00%) 7:12 PM ET
4-Sell of 5 4
C Value A Growth D Momentum B VGM
Cash flow Statements
Fiscal Year End for LifeMD, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -17.84 | -45.02 | -61.32 | -60.52 | -3.53 |
Depreciation/Amortization & Depletion | 6.93 | 12.63 | 2.96 | 1.21 | 0.96 |
Net Change from Assets/Liabilities | 4.91 | -1.55 | 9.13 | 8.87 | 2.07 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 14.82 | 11.00 | 16.15 | 38.31 | 0.76 |
Net Cash From Operating Activities | 8.82 | -22.94 | -33.09 | -12.13 | 0.25 |
Property & Equipment | -8.58 | -8.89 | -3.38 | -0.40 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | -1.01 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | -0.15 | -4.00 | -0.02 | -0.40 | -0.10 |
Net Cash from Investing Activities | -8.73 | -13.91 | -3.40 | -0.80 | -0.10 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 16.30 | 0.13 | 70.48 | 21.08 | 0.35 |
Issuance (Repayment) of Debt | 16.67 | 2.74 | -0.53 | -2.26 | -0.30 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 2.35 | 1.09 |
Payment of Dividends & Other Distributions | -3.11 | -3.11 | -0.87 | 0.00 | 0.00 |
Other Financing Activities | -0.76 | -0.29 | -0.44 | -0.17 | -0.37 |
Net Cash from Financing Activities | 29.10 | -0.53 | 68.64 | 21.00 | 0.78 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 29.19 | -37.37 | 32.15 | 8.07 | 0.93 |
Cash at Beginning of Period | 3.96 | 41.33 | 9.18 | 1.11 | 0.18 |
Cash at End of Period | 33.15 | 3.96 | 41.33 | 9.18 | 1.11 |
Diluted Net EPS | -0.70 | -1.57 | -2.29 | -4.44 | -0.35 |
Fiscal Year End for LifeMD, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -13.49 | -6.65 | -17.84 | -14.62 | -9.33 |
Depreciation/Amortization & Depletion | 4.59 | 2.20 | 6.93 | 4.89 | 3.08 |
Net Change from Assets/Liabilities | 11.50 | 6.89 | 4.91 | 2.42 | 1.95 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 7.14 | 2.76 | 14.82 | 10.41 | 6.34 |
Net Cash From Operating Activities | 9.74 | 5.20 | 8.82 | 3.11 | 2.03 |
Property & Equipment | -5.32 | -2.19 | -8.58 | -6.37 | -3.96 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | -0.15 | -0.15 | -0.15 |
Net Cash from Investing Activities | -5.32 | -2.19 | -8.73 | -6.52 | -4.11 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.11 | 0.01 | 16.30 | 0.90 | 0.00 |
Issuance (Repayment) of Debt | -0.31 | -0.21 | 16.67 | 16.77 | 12.09 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | -1.55 | -0.78 | -3.11 | -2.33 | -1.55 |
Other Financing Activities | -0.10 | -0.07 | -0.76 | -0.60 | -0.50 |
Net Cash from Financing Activities | -1.86 | -1.05 | 29.10 | 14.74 | 10.03 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 2.56 | 1.96 | 29.19 | 11.33 | 7.95 |
Cash at Beginning of Period | 33.15 | 33.15 | 3.96 | 3.96 | 3.96 |
Cash at End of Period | 35.70 | 35.11 | 33.15 | 15.29 | 11.91 |
Diluted Net EPS | -0.19 | -0.19 | -0.12 | -0.20 | -0.23 |